Which brands are affected?

The following brands are affected: LEVOTHYROXINE SODIUM, Major Pharmaceuticals.

Which model numbers are affected?

Affected models: Lot# N02172, exp 07/2026, N02296, N02288, Exp. Date 12/2026.

HIGHFDA DRUGJuly 13, 2026

Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. ...

Official notice

LEVOTHYROXINE SODIUM Major Pharmaceuticals Health & Personal Care Drugs & MedicationsLot# N02172exp 07/2026N02296

Source-backed recall notice

No product image was available from the source feed.

Official source: FDA DRUG
Recall date: July 13, 2026
Status: ACTIVE

Quick Facts at a Glance

Recall Date: July 13, 2026
Hazard Level: HIGH
Brands: LEVOTHYROXINE SODIUM, Major Pharmaceuticals
Geographic Scope: 1 states

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

1Stop using the product until you confirm whether it is included in the recall.
2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand: LEVOTHYROXINE SODIUM, Major Pharmaceuticals
Model numbers: Lot# N02172, exp 07/2026, N02296, N02288, Exp. Date 12/2026
UPC codes: 0904-6949, 0904-6950, 0904-6951, 0904-6952, 0904-6953, 0904-6954, 0904-6955, 0904-6956 +10 more
Where affected: ALL

Recall Timeline

Key dates and source checks for this recall record.

Recall announced
July 13, 2026
Reported by FDA DRUG
July 29, 2026
RecallRadar source check
August 4, 2026
Consumer action
Use the official remedy and keep documentation.

Hazard Information

Subpotent Drug

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Major Pharmaceuticals or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for LEVOTHYROXINE SODIUM recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Full Description

Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6951-61. Generic: LEVOTHYROXINE SODIUM; Brand: LEVOTHYROXINE SODIUM. Reason: Subpotent Drug. Classification: Class II. Quantity: N/A. Distribution: Nationwide in the USA.

View Original Recall on FDA - Drug Safety